Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Oncogene|October 7, 2003
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Maresa Altomonte, Ester Fonsatti, Alberto Visintin, et al.Journal of Endotoxin Research|December 14, 2004
Mechanisms of TLR9 activationEicke Latz, Alberto Visintin, Terje Espevik, et al.The Journal of Biological Chemistry|September 10, 2003
Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transductionAlberto Visintin, Eicke Latz, Brian G Monks, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2Alberto Visintin, Kristen A Halmen, Eicke Latz, et al.European Journal of Immunology|April 5, 2002
Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cellsJessica H Spitzer, Alberto Visintin, Alessandra Mazzoni, et al.Journal of Endotoxin Research|January 22, 2004
The LPS receptor generates inflammatory signals from the cell surfaceEicke Latz, Alberto Visintin, Egil Lien, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide toleranceElke Cario, Douglas T Golenbock, Alberto Visintin, et al.The Journal of Biological Chemistry|November 19, 2005
Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogenCatherine M O'Connell, Irina A Ionova, Alison J Quayle, et al.Journal of Leukocyte Biology|September 2, 2006
MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4)Alberto Visintin, Kristen A Halmen, Naseema Khan, et al.Pageof 4